Osteopontin Expression Is Associated with the Poor Prognosis in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
Background. The osteopontin has been involved in therapeutic resistance in a variety of cancers. But, the significance of osteopontin expression on the prognosis of patients with locally advanced esophageal squamous cell carcinoma (ESCC) receiving chemoradiotherapy is unclear. Methods. In 80 patient...
Main Authors: | Tai-Jan Chiu, Hung-I Lu, Chang-Han Chen, Wan-Ting Huang, Yu-Ming Wang, Wei-Che Lin, Shau-Hsuan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2018/9098215 |
Similar Items
-
The Impact of Radiotherapy Dose in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
by: Chien-Ming Lo, et al.
Published: (2021-03-01) -
Galectin-1 Expression Is Associated with the Response and Survival Following Preoperative Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma
by: Shau-Hsuan Li, et al.
Published: (2021-06-01) -
Preoperative Chemoradiotherapy followed by Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: a Single Center Experience in Southern Taiwan
by: Chien-Ming Lo, et al.
Published: (2014-12-01) -
Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma
by: Sheng-Dean Luo, et al.
Published: (2015-01-01) -
Positive Programmed Cell Death-Ligand 1 Expression Predicts Poor Treatment Outcomes in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy
by: Wan-Ting Huang, et al.
Published: (2019-11-01)